Pharmagen Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Mar '14 Mar 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010
Net Income	-5.87	-6	-2.77	-0.3	-0.01
Depreciation & Amortization	0.11	0.1	0.03	0.03	-
Other Amortization	2.53	2.57	0.61	-	-
Asset Writedown & Restructuring Costs	1.2	1.2	-	-	-
Stock-Based Compensation	0.15	0.12	-	-	-
Other Operating Activities	-0.59	-0.36	-0.04	0.05	-
Change in Accounts Receivable	0.44	0.27	-0.35	-0.17	-0.05
Change in Inventory	0.01	0.01	-0.11	0	0.01
Change in Accounts Payable	1.1	0.95	0.62	0.09	0
Change in Other Net Operating Assets	0.44	0.46	-0.17	0.04	0.05
Operating Cash Flow	-0.48	-0.69	-2.18	-0.25	0.01
Capital Expenditures	-0.1	-0.06	-0.09	-0.06	-
Cash Acquisitions	-	-	-0.08	-	-
Investing Cash Flow	-0.1	-0.06	-0.17	-0.06	-
Short-Term Debt Issued	-	-	-	0.34	-
Long-Term Debt Issued	-	0.76	2.69	-	-
Total Debt Issued	0.2	0.76	2.69	0.34	-
Short-Term Debt Repaid	-	-	-0.05	-	-0.01
Long-Term Debt Repaid	-	-0.19	-	-	-
Total Debt Repaid	-0.22	-0.19	-0.05	-	-0.01
Net Debt Issued (Repaid)	-0.02	0.56	2.64	0.34	-0.01
Issuance of Common Stock	-	-	-	-	0
Other Financing Activities	-	-0.04	-	-	-
Financing Cash Flow	0.2	0.65	2.64	0.34	-0
Net Cash Flow	-0.38	-0.1	0.28	0.03	0
Free Cash Flow	-0.59	-0.75	-2.28	-0.31	0.01
Free Cash Flow Margin	-13.28%	-15.56%	-53.41%	-36.10%	9.36%
Free Cash Flow Per Share	-0.00	-0.00	-0.01	-0.00	-
Cash Interest Paid	0.03	0.02	0.02	0.01	0.01
Levered Free Cash Flow	4.41	3.46	-1.58	-0.21	-
Unlevered Free Cash Flow	3.77	2.77	-1.7	-0.2	-
Change in Working Capital	1.99	1.69	-0.01	-0.03	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.